One pharmacist's take on the recent Amazon news.
Specialty pharmaceuticals will have a growing impact on pharmacists. Here’s how it could change your role.
Reimbursement issues, sadly, aren’t anything new for pharmacies.
AACP offers a rebuttal to a Drug Topics opinion article.
PBMs have a business model where they pay less even while prices go up.
A 60-year debate accompanied the elevation of pharmacy education to the doctoral level. When the provider status bill now moving through Congress is enacted into law, it will put paid to that particular conversation.
Quasi-religious symbol? Sign of enforced conformity? Emblem of arrogance and superiority? Or simple professional attire? You decide.
If nothing changes between now and 2018, we may see a 25% oversupply of pharmacists in the marketplace. Then again, we may not. What happens between now and then is, in large measure, up to us.
Sometimes it's not the demanding customers or condescending physicians, it's their own colleagues who drive pharmacists right up the wall.
How did local drugstores end up at the mercy of drugmakers, pharmacy chains, insurance plans, and PBMs? Here's a look back from someone who watched it happen.